6.
Brunner J, Lammertse H, van Berkel A, Koopmans F, Li K, Smit A
. Power and optimal study design in iPSC-based brain disease modelling. Mol Psychiatry. 2022; 28(4):1545-1556.
PMC: 10208961.
DOI: 10.1038/s41380-022-01866-3.
View
7.
Liu B, Chen X, Wang Z, Tong W
. Nbn gene inactivation in the CNS of mouse inhibits the myelinating ability of the mature cortical oligodendrocytes. Glia. 2013; 62(1):133-44.
DOI: 10.1002/glia.22593.
View
8.
Moossy J
. The neuropathology of Cockayne's syndrome. J Neuropathol Exp Neurol. 1967; 26(4):654-60.
DOI: 10.1097/00005072-196710000-00010.
View
9.
Majora M, Sondenheimer K, Knechten M, Uthe I, Esser C, Schiavi A
. HDAC inhibition improves autophagic and lysosomal function to prevent loss of subcutaneous fat in a mouse model of Cockayne syndrome. Sci Transl Med. 2018; 10(456).
DOI: 10.1126/scitranslmed.aam7510.
View
10.
Arrowsmith J, Miller P
. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov. 2013; 12(8):569.
DOI: 10.1038/nrd4090.
View
11.
Vasudevan P, Suri M
. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond). 2017; 17(6):558-561.
PMC: 6297696.
DOI: 10.7861/clinmedicine.17-6-558.
View
12.
Hernandez S, Fote G, Reyes-Ortiz A, Steffan J, Thompson L
. Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease. Matrix Biol Plus. 2021; 12:100089.
PMC: 8579148.
DOI: 10.1016/j.mbplus.2021.100089.
View
13.
Chesnut M, Hartung T, Hogberg H, Pamies D
. Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity. Int J Mol Sci. 2021; 22(15).
PMC: 8347131.
DOI: 10.3390/ijms22157929.
View
14.
Poirier K, Lebrun N, Broix L, Tian G, Saillour Y, Boscheron C
. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet. 2013; 45(6):639-47.
PMC: 3826256.
DOI: 10.1038/ng.2613.
View
15.
Pasca A, Sloan S, Clarke L, Tian Y, Makinson C, Huber N
. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015; 12(7):671-8.
PMC: 4489980.
DOI: 10.1038/nmeth.3415.
View
16.
van der Horst G, van Steeg H, Berg R, van Gool A, de Wit J, Weeda G
. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 1997; 89(3):425-35.
DOI: 10.1016/s0092-8674(00)80223-8.
View
17.
Allen N, Lyons D
. Glia as architects of central nervous system formation and function. Science. 2018; 362(6411):181-185.
PMC: 6292669.
DOI: 10.1126/science.aat0473.
View
18.
Szepanowski L, Wruck W, Kapr J, Rossi A, Fritsche E, Krutmann J
. Cockayne Syndrome Patient iPSC-Derived Brain Organoids and Neurospheres Show Early Transcriptional Dysregulation of Biological Processes Associated with Brain Development and Metabolism. Cells. 2024; 13(7.
PMC: 11011893.
DOI: 10.3390/cells13070591.
View
19.
Vessoni A, Herai R, Karpiak J, Leal A, Trujillo C, Quinet A
. Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony. Hum Mol Genet. 2016; 25(7):1271-80.
PMC: 4787902.
DOI: 10.1093/hmg/ddw008.
View
20.
Noack M, Leyk J, Richter-Landsberg C
. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes. Glia. 2014; 62(4):535-47.
DOI: 10.1002/glia.22624.
View